Published in Thromb Res on January 01, 2003
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med (2010) 1.49
Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol (2009) 1.28
A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J (2010) 1.23
White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study). Am J Cardiol (2011) 1.22
Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest (2009) 1.15
Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.11
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm (2016) 0.94
Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly Han Chinese patients with essential hypertension. J Interferon Cytokine Res (2012) 0.92
Coagulation, protease-activated receptors, and viral myocarditis. J Cardiovasc Transl Res (2013) 0.91
Response of high-sensitive C-reactive protein to catheter ablation of atrial fibrillation and its relation with rhythm outcome. PLoS One (2012) 0.87
Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study. Eur J Epidemiol (2011) 0.80
Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage. Korean Circ J (2009) 0.79
Modulation of both activator protein-1 and nuclear factor-kappa B signal transduction of human T cells by amiodarone. Exp Biol Med (Maywood) (2014) 0.77
Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion. ISRN Cardiol (2011) 0.75
Inflammatory cytokines and atrial fibrillation: current and prospective views. J Inflamm Res (2010) 0.75
Intrinsic Cardiac Autonomic Ganglionated Plexi within Epicardial Fats Modulate the Atrial Substrate Remodeling: Experiences with Atrial Fibrillation Patients Receiving Catheter Ablation. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.75
PD-1/PD-L1 expression on CD(4+) T cells and myeloid DCs correlates with the immune pathogenesis of atrial fibrillation. J Cell Mol Med (2015) 0.75
Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythm. PLoS One (2017) 0.75
vWF correlates with visceral and pericardial adipose tissue in patients with a recent stroke of suspected cardiogenic etiology. PLoS One (2017) 0.75
Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation (2004) 3.16
Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead. J Am Coll Cardiol (2002) 2.01
Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm (2007) 1.80
Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial. J Am Coll Cardiol (2010) 1.76
Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J Biol Chem (2004) 1.75
Site-specific arrhythmogenesis in patients with Brugada syndrome. J Cardiovasc Electrophysiol (2003) 1.73
Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv (2012) 1.65
Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy. Circ J (2011) 1.64
Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study). Europace (2010) 1.63
Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation (2008) 1.62
Marked hemodynamic improvements by high-dose epoprostenol therapy in patients with idiopathic pulmonary arterial hypertension. Circ J (2010) 1.62
Endogenous bone-marrow-derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model. J Heart Lung Transplant (2005) 1.60
Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. Circ J (2008) 1.57
A novel KCNH2 mutation as a modifier for short QT interval. Int J Cardiol (2008) 1.57
Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension. Circ J (2013) 1.57
Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome. J Cardiovasc Electrophysiol (2007) 1.55
Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome. J Am Coll Cardiol (2008) 1.54
Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm (2004) 1.53
Novel SCN3B mutation associated with brugada syndrome affects intracellular trafficking and function of Nav1.5. Circ J (2012) 1.52
Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome. Heart Rhythm (2010) 1.52
Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in Japan. J Am Coll Cardiol (2004) 1.51
Spontaneous electrocardiogram alterations predict ventricular fibrillation in Brugada syndrome. Heart Rhythm (2011) 1.51
Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon. Eur Heart J (2009) 1.46
Enhanced expression of haemoglobin scavenger receptor in accumulated macrophages of culprit lesions in acute coronary syndromes. Eur Heart J (2009) 1.43
First International Summit on Thoracic Aortic Endografting: roundtable on thoracic aortic dissection as an indication for endografting. J Endovasc Ther (2002) 1.40
Reduced diurnal variation of heart rate is associated with increased plasma B-type natriuretic peptide level in patients with atrial fibrillation. Clin Cardiol (2013) 1.40
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol (2003) 1.35
Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am Coll Cardiol (2008) 1.33
Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation (2002) 1.32
Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum (2003) 1.31
Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythm Electrophysiol (2009) 1.25
Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol (2008) 1.24
Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm (2007) 1.23
Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol (2002) 1.21
Continued growth of and increased symptoms from a thrombosed giant aneurysm of the vertebral artery after complete endovascular occlusion and trapping: the role of vasa vasorum. Case report. J Neurosurg (2003) 1.21
Spontaneous T wave alternans and premature ventricular contractions during febrile illness in a patient with Brugada syndrome. J Cardiovasc Electrophysiol (2002) 1.20
Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation (2003) 1.18
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension. Hum Mutat (2011) 1.18
Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy. J Muscle Res Cell Motil (2005) 1.16
A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. PLoS One (2013) 1.15
Role of pim-1 in smooth muscle cell proliferation. J Biol Chem (2004) 1.13
DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study. Cardiovasc Diabetol (2014) 1.12
Sarcomere-length dependence of lattice volume and radial mass transfer of myosin cross-bridges in rat papillary muscle. Pflugers Arch (2004) 1.11
Pressor effect of electroacupuncture on hemorrhagic hypotension. Am J Physiol Regul Integr Comp Physiol (2003) 1.10
The predictors of central and obstructive sleep apnoea in haemodialysis patients. Nephrol Dial Transplant (2007) 1.10
Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol (2003) 1.05
Cardiac tumors that cause arrhythmias. Card Electrophysiol Rev (2002) 1.04
Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol (2002) 1.02
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. Circ Arrhythm Electrophysiol (2012) 1.02
Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy. J Card Fail (2005) 1.01
G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell Transplant (2004) 1.01
Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis. Circ J (2004) 1.00
Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT). Int Heart J (2006) 0.99
Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report. Cardiovasc Diabetol (2013) 0.99
Trends in the clinical and morphological characteristics of cardiac myxoma: 20-year experience of a single tertiary referral center in Japan. Circ J (2002) 0.99
Prevention of catheter-related infections using a closed hub system in patients with pulmonary arterial hypertension. Circ J (2007) 0.99
Identification of high-risk syncope related to ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm (2011) 0.97
Left atrial volume combined with atrial pump function identifies hypertensive patients with a history of paroxysmal atrial fibrillation. Hypertension (2010) 0.96
Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro. J Thorac Cardiovasc Surg (2003) 0.96
Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome. Eur Heart J (2006) 0.96
Malignant peripheral nerve sheath tumor associated with neurofibromatosis type 1, with metastasis to the heart: a case report. Diagn Pathol (2010) 0.96
C-type natriuretic peptide ameliorates monocrotaline-induced pulmonary hypertension in rats. Am J Respir Crit Care Med (2004) 0.95
Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease. Pediatr Int (2004) 0.95
Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. Intern Med (2013) 0.94
Comparison of coronary and aortic atherosclerosis in youth from Japan and the USA. Atherosclerosis (2005) 0.94
Direct observation of epicardial coronary capillary hemodynamics during reactive hyperemia and during adenosine administration by intravital video microscopy. Am J Physiol Heart Circ Physiol (2004) 0.94